Status:
COMPLETED
Detection Rate of Serrated Adenomas in Screening Colonoscopy
Lead Sponsor:
TriHealth Inc.
Collaborating Sponsors:
TriHealth Hatton Research Institute
Conditions:
Healthy Patients Undergoing Screening Colonoscopy
Eligibility:
All Genders
18+ years
Brief Summary
An observational prospective will be conducted to determine the detection rate of serrated adenoma during screening colonoscopy at our institution. Additionally, the variability of serrated adenoma de...
Detailed Description
Colonoscopy screening is a preventative measure for colorectal carcinoma (CRC), a highly malignant and dangerous cancer. Extensive research on the adenoma detection rate has provided national standard...
Eligibility Criteria
Inclusion
- Males and females
Exclusion
- First degree relative (patient's parent, sibling or child) diagnosed with colorectal carcinoma at age of 59 or under
- New onset of iron deficiency anemia (within past 3 months)
- Abnormal imaging of colon within past 3 months
- Inadequate visualization reported by endoscopist
- Pregnant women
Key Trial Info
Start Date :
March 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 7 2018
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT03442270
Start Date
March 20 2018
End Date
November 7 2018
Last Update
June 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Good Samaritan Hospital
Cincinnati, Ohio, United States, 45220